CRSP Cost of Revenue

Crispr Therapeutics Ag · Cost of Revenue

CRSP logo

CRSP Cost of Revenue

Latest reported$218.88M
CRSP Cost of Revenue ($1.51M → $218.88M)
High-resolution chart · PNG

CRSP cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
232,959,000
110,250,000
130,250,000
110,250,000
101,178,000
269,407,000
179,362,000
113,773,000
69,800,000
42,238,000
12,573,000
1,513,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.